| Leclerq R, Courvalin P. Bacterial resistance to macrolides, lincosamide and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991;35:1267-72.Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002;34:482-92.Ioannidou S, Tassios PT, Kotsovili-Tseleni A, Foustoukou M, Legakis NJ, Vatopoulus A. Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children. Int J Antimicrob Agents 2001;17.195-201.Seral C, Castillo FJ, Rubio-Calvo MC, Fenoll A, García C, Gómez-Lus R. Distribution of resistance genes tet(M), aph3´-III, catpc194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(A) genes in Spain. J Antimicrob Chemother 2001;47:863-6.Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 2002;15:613-30.Seppälä H, Nissinen A, Yu Q, Huovinen P. Three different phenotypes of erithromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 1993;32:885-91.Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996;40:2562-6.Rodriguez-Avial I, Rodriguez-Avial C, Culebras E, Benítez A, Picazo JJ. Distribution of mef(A) and erm(B) genes in macrolide-resistant blood isolates of viridans group streptococci. J Antimicrob Chemother 2001;47:727-8.Arpin C, Canron MH, Maugein J, Quentin C. Incidence of mefA and mefE genes in viridans group streptococci. Antimicrob Agents Chemother 1999;43:2335-6.Jacobs JA, van Barr GJ, London NHHJ, et al. Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group. Antimicrob Agents Chemother 2001;45:2375-7.Johnston NJ; De Azavedo C; Kellner JD; Low DE. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin in resistance isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1998;42:2425-6.Rice L. Tn916 family conjugative transposons and dissemination of antimicrobial resistance determinants. Antimicrob Agents Chemother 1998;42:1871-7.Buu-Hoï A, Sapoetra A, Branger C, Acar JF. Antimicrobial susceptibility of Gemella haemolysans isolated from patients with subacute endocarditis. Eur J Clin Microbiol 1982;1:102-6. |
| Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and its transfer to S. pneumoniae. Paula Cerdá Zolezzi, Leticia Millán Laplana, Carmen Rubio Calvo, Pilar Goñi Cepero, Melisa Canales Erazo, and Rafael Gómez.Lus. Antimicrobial Agents and Chemotherapy. 2004.48 (9).In vitro activity of telithromycin, quinupristin/dalfopristin, linezolid and comparator antimicrobial agents against Staphylococcus aureus clinical isolates. L. Millán, P. Cerdá, M.C. Rubio, P. Goñi, M. Canales, S. Capilla, M. Oca, R. Gómez-Lus. Journal of Chemotherapy. En prensa.Epidemiological study of resistance to nalidixic acid and other antibiotics in clinical Yersinia enterocolitica O:3 isolates. S. Capilla, P. Goñi, M.C. Rubio, J. Castillo, L. Millán, P. Cerdá, J. Sahún, C. Pitart, A. Beltrán, and R. Gómez-Lus. Journal of Clinical Microbiology. 2003. 41:4876-4878. |
